Growing Through Challenges? – GoHealth Inc. (GOCO)


T. Rowe Price Associates, Inc. (I. recently announced the acquisition of new stake in GoHealth Inc. (NASDAQ:GOCO). This fresh investment now brings its stake to 10.47% valued currently at $156.42 million. In addition, Viking Global Investors LP raised its holdings by 4.56 million to 4.56 million shares.

With over 2.11 million GoHealth Inc. (GOCO) shares trading Monday and a closing price of $15.51 on the day, the dollar volume was approximately $32.8 million. The shares have shown a negative weekly performance of -19.18% and its price on 08/24/20 lost nearly -2.88%. Currently, there are 334.40M common shares owned by the public and among those 43.40M shares have been available to trade.

An analysis of what Wall Street brokers have to say about the expected price targets for this stock gives us this picture: 10 analysts who have offered their price forecasts for GOCO have a consensus price objective of $23.44. The analysts have set the share’s price value over the next 12 months at a high of $27.00 and a low of $18.00 should the stock experience a downside. Incidentally, analysts’ outlook for the GoHealth Inc. stock is 1.90 for the next 12 months. The average price target is 33.83% above its last price level and an upside to the estimated low will see the stock gain 13.83% over that period. But an upside of 42.56% will see the stock hit the forecast high price target while mean target price for the stock is $23.00.

Insiders at the company have transacted a total of 11 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 6 of these insider trades were purchases, accounting for 97,621 shares. Insider sales of the common stock occurred on 5 occasions, with total insider shares sold totaling 32,953,201 shares.

The top 3 mutual fund holders in GoHealth Inc. are Carmignac Investissement, Vanguard Total Stock Market Index, and Vanguard Small Cap Index Fund. Carmignac Investissement owns 2.0 million shares of the company’s stock, all valued at over $35.55 million. The company bought an additional 2.0 million shares recently to bring their total holdings to about 2.38% of the shares outstanding. Vanguard Small Cap Index Fund bought 1.11 million shares to bring its total holdings to over 1.11 million shares at a value of $19.63 million. Vanguard Small Cap Index Fund now owns shares totaling to 1.31% of the shares outstanding.

Shares of GoHealth Inc. (NASDAQ: GOCO) opened at $16.05, up $0.08 from a prior closing price of $15.97. However, the script later closed the day at $15.51, down -2.88%. It has a 12-month low price of $15.14 and touched a high of $26.25 over the same period. Currently, 2.11 million shares have been traded, compared to an average intraday trading volume of 3.51 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -11.82%, -16.00%, and -16.00% respectively.

Institutional ownership of GoHealth Inc. (NASDAQ: GOCO) 334.40M shares outstanding. Mutual fund holders own 10.19%, while other institutional holders and individual stakeholders account for 8.23% and — respectively.

It has a market capitalization of $5.19B. Price movements for the stock have been influenced by the stock’s volatility, which stands at 8.45% over the week and 7.26% over the month.

Analysts forecast that GoHealth Inc. (GOCO) will achieve an EPS of $0 for the current quarter, $0.49 for the next quarter and $0.8 for 2021. The lowest estimate earnings-per-share for the quarter is -$0.02 while analysts give the company a high EPS estimate of $0.04. Earnings per share for the fiscal year are expected to decrease by -246.10%, and 95.30% over the next financial year.

If you are looking to buy this stock, then you may note that the average analyst recommendation by 10 brokerage firm advisors rate GoHealth Inc. (GOCO) as a “Strong Buy” at a consensus score of 1.90. Specifically, 9 Wall Street analysts polled rate the stock as a buy, while 1 of the 10 advise that investors “hold,” and 0 rated it as a “Sell.”

Looking at the support for the GOCO, a number of firms have released research notes about the stock. William Blair stated their Outperform rating for the stock in a research note on August 11, 2020, with the firm’s price target at. RBC Capital Mkts coverage for the GoHealth Inc. (GOCO) stock in a research note released on August 10, 2020 offered a Outperform rating with a price target of $22. Morgan Stanley was of a view on August 10, 2020 that the stock is Equal-Weight, while Goldman gave the stock Buy rating on August 10, 2020, issuing a price target of $21. Evercore ISI on their part issued Outperform rating on August 10, 2020.


Please enter your comment!
Please enter your name here